Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7554 |
Intermediate Similarity |
NPD8339 |
Clinical (unspecified phase) |
0.6862 |
Remote Similarity |
NPD6632 |
Clinical (unspecified phase) |
0.6802 |
Remote Similarity |
NPD1004 |
Phase 2 |
0.6802 |
Remote Similarity |
NPD1005 |
Phase 2 |
0.6754 |
Remote Similarity |
NPD4949 |
Discontinued |
0.6738 |
Remote Similarity |
NPD7977 |
Clinical (unspecified phase) |
0.67 |
Remote Similarity |
NPD8071 |
Approved |
0.6667 |
Remote Similarity |
NPD6092 |
Discontinued |
0.6649 |
Remote Similarity |
NPD6044 |
Discontinued |
0.6647 |
Remote Similarity |
NPD740 |
Clinical (unspecified phase) |
0.6607 |
Remote Similarity |
NPD206 |
Clinical (unspecified phase) |
0.6584 |
Remote Similarity |
NPD8260 |
Approved |
0.6583 |
Remote Similarity |
NPD7321 |
Clinical (unspecified phase) |
0.6562 |
Remote Similarity |
NPD6349 |
Phase 1 |
0.6554 |
Remote Similarity |
NPD5189 |
Clinical (unspecified phase) |
0.6537 |
Remote Similarity |
NPD7195 |
Clinical (unspecified phase) |
0.6529 |
Remote Similarity |
NPD714 |
Clinical (unspecified phase) |
0.6528 |
Remote Similarity |
NPD6348 |
Clinical (unspecified phase) |
0.648 |
Remote Similarity |
NPD5634 |
Approved |
0.6457 |
Remote Similarity |
NPD1939 |
Approved |
0.6437 |
Remote Similarity |
NPD649 |
Clinical (unspecified phase) |
0.6333 |
Remote Similarity |
NPD4436 |
Clinical (unspecified phase) |
0.6304 |
Remote Similarity |
NPD1545 |
Discontinued |
0.6294 |
Remote Similarity |
NPD3288 |
Approved |
0.6284 |
Remote Similarity |
NPD3272 |
Approved |
0.6284 |
Remote Similarity |
NPD3273 |
Approved |
0.6283 |
Remote Similarity |
NPD7104 |
Clinical (unspecified phase) |
0.6263 |
Remote Similarity |
NPD5755 |
Clinical (unspecified phase) |
0.6237 |
Remote Similarity |
NPD5636 |
Discontinued |
0.623 |
Remote Similarity |
NPD3388 |
Phase 1 |
0.6223 |
Remote Similarity |
NPD754 |
Clinical (unspecified phase) |
0.6214 |
Remote Similarity |
NPD5864 |
Phase 2 |
0.6209 |
Remote Similarity |
NPD2767 |
Approved |
0.6209 |
Remote Similarity |
NPD2768 |
Approved |
0.6207 |
Remote Similarity |
NPD1881 |
Approved |
0.6204 |
Remote Similarity |
NPD5987 |
Approved |
0.6204 |
Remote Similarity |
NPD5986 |
Approved |
0.6193 |
Remote Similarity |
NPD4510 |
Discontinued |
0.6188 |
Remote Similarity |
NPD7049 |
Clinical (unspecified phase) |
0.6185 |
Remote Similarity |
NPD201 |
Phase 2 |
0.6185 |
Remote Similarity |
NPD200 |
Phase 2 |
0.615 |
Remote Similarity |
NPD3929 |
Clinical (unspecified phase) |
0.6138 |
Remote Similarity |
NPD647 |
Approved |
0.6131 |
Remote Similarity |
NPD7127 |
Clinical (unspecified phase) |
0.6117 |
Remote Similarity |
NPD8272 |
Phase 2 |
0.6103 |
Remote Similarity |
NPD2417 |
Approved |
0.6103 |
Remote Similarity |
NPD2416 |
Approved |
0.61 |
Remote Similarity |
NPD2717 |
Phase 2 |
0.6091 |
Remote Similarity |
NPD5590 |
Clinical (unspecified phase) |
0.6087 |
Remote Similarity |
NPD2849 |
Clinical (unspecified phase) |
0.6082 |
Remote Similarity |
NPD963 |
Discontinued |
0.6058 |
Remote Similarity |
NPD5011 |
Clinical (unspecified phase) |
0.6029 |
Remote Similarity |
NPD2548 |
Clinical (unspecified phase) |
0.6029 |
Remote Similarity |
NPD6239 |
Discontinued |
0.6019 |
Remote Similarity |
NPD3015 |
Discontinued |
0.601 |
Remote Similarity |
NPD7289 |
Clinical (unspecified phase) |
0.601 |
Remote Similarity |
NPD6156 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD6389 |
Clinical (unspecified phase) |
0.599 |
Remote Similarity |
NPD2299 |
Phase 1 |
0.5989 |
Remote Similarity |
NPD4384 |
Clinical (unspecified phase) |
0.5988 |
Remote Similarity |
NPD4680 |
Discontinued |
0.598 |
Remote Similarity |
NPD3469 |
Phase 3 |
0.5979 |
Remote Similarity |
NPD4174 |
Clinical (unspecified phase) |
0.5969 |
Remote Similarity |
NPD5092 |
Clinical (unspecified phase) |
0.5967 |
Remote Similarity |
NPD2089 |
Clinical (unspecified phase) |
0.5955 |
Remote Similarity |
NPD7711 |
Discontinued |
0.5944 |
Remote Similarity |
NPD9725 |
Approved |
0.5943 |
Remote Similarity |
NPD792 |
Discontinued |
0.5935 |
Remote Similarity |
NPD3848 |
Phase 2 |
0.5922 |
Remote Similarity |
NPD5814 |
Approved |
0.5922 |
Remote Similarity |
NPD5813 |
Approved |
0.592 |
Remote Similarity |
NPD5260 |
Approved |
0.592 |
Remote Similarity |
NPD5258 |
Approved |
0.592 |
Remote Similarity |
NPD1977 |
Clinical (unspecified phase) |
0.5916 |
Remote Similarity |
NPD4973 |
Approved |
0.5909 |
Remote Similarity |
NPD3279 |
Phase 2 |
0.5906 |
Remote Similarity |
NPD4125 |
Approved |
0.5904 |
Remote Similarity |
NPD5315 |
Discontinued |
0.59 |
Remote Similarity |
NPD2850 |
Phase 1 |
0.59 |
Remote Similarity |
NPD2851 |
Clinical (unspecified phase) |
0.5899 |
Remote Similarity |
NPD5893 |
Discontinued |
0.5896 |
Remote Similarity |
NPD2806 |
Phase 2 |
0.5889 |
Remote Similarity |
NPD5503 |
Approved |
0.5889 |
Remote Similarity |
NPD5502 |
Approved |
0.5888 |
Remote Similarity |
NPD1745 |
Approved |
0.5888 |
Remote Similarity |
NPD5106 |
Approved |
0.5888 |
Remote Similarity |
NPD5105 |
Approved |
0.5885 |
Remote Similarity |
NPD4906 |
Approved |
0.5885 |
Remote Similarity |
NPD4905 |
Approved |
0.5885 |
Remote Similarity |
NPD4903 |
Approved |
0.5879 |
Remote Similarity |
NPD1661 |
Suspended |
0.5879 |
Remote Similarity |
NPD6217 |
Discontinued |
0.5874 |
Remote Similarity |
NPD5828 |
Phase 2 |
0.5872 |
Remote Similarity |
NPD4933 |
Clinical (unspecified phase) |
0.5871 |
Remote Similarity |
NPD3474 |
Discovery |
0.5871 |
Remote Similarity |
NPD2755 |
Discontinued |
0.587 |
Remote Similarity |
NPD5965 |
Clinical (unspecified phase) |
0.5869 |
Remote Similarity |
NPD3223 |
Clinical (unspecified phase) |
0.5869 |
Remote Similarity |
NPD2784 |
Clinical (unspecified phase) |
0.5869 |
Remote Similarity |
NPD5470 |
Clinical (unspecified phase) |
0.5868 |
Remote Similarity |
NPD268 |
Approved |
0.5868 |
Remote Similarity |
NPD271 |
Approved |
0.5868 |
Remote Similarity |
NPD270 |
Clinical (unspecified phase) |
0.5867 |
Remote Similarity |
NPD3927 |
Phase 2 |
0.5864 |
Remote Similarity |
NPD5094 |
Approved |
0.5864 |
Remote Similarity |
NPD2413 |
Phase 2 |
0.5857 |
Remote Similarity |
NPD4904 |
Approved |
0.5851 |
Remote Similarity |
NPD2511 |
Approved |
0.5847 |
Remote Similarity |
NPD1188 |
Approved |
0.5843 |
Remote Similarity |
NPD2073 |
Approved |
0.5843 |
Remote Similarity |
NPD2022 |
Approved |
0.5843 |
Remote Similarity |
NPD2075 |
Approved |
0.5843 |
Remote Similarity |
NPD2087 |
Approved |
0.5843 |
Remote Similarity |
NPD2088 |
Approved |
0.5843 |
Remote Similarity |
NPD2074 |
Approved |
0.5843 |
Remote Similarity |
NPD2072 |
Approved |
0.5838 |
Remote Similarity |
NPD3476 |
Approved |
0.5838 |
Remote Similarity |
NPD3475 |
Approved |
0.5838 |
Remote Similarity |
NPD4011 |
Clinical (unspecified phase) |
0.5837 |
Remote Similarity |
NPD6888 |
Discontinued |
0.5833 |
Remote Similarity |
NPD3395 |
Approved |
0.5833 |
Remote Similarity |
NPD3396 |
Approved |
0.5833 |
Remote Similarity |
NPD5904 |
Clinical (unspecified phase) |
0.5833 |
Remote Similarity |
NPD5702 |
Clinical (unspecified phase) |
0.5829 |
Remote Similarity |
NPD4415 |
Approved |
0.5825 |
Remote Similarity |
NPD1260 |
Approved |
0.5822 |
Remote Similarity |
NPD2853 |
Approved |
0.5822 |
Remote Similarity |
NPD4928 |
Approved |
0.5822 |
Remote Similarity |
NPD4929 |
Approved |
0.5822 |
Remote Similarity |
NPD4930 |
Approved |
0.5821 |
Remote Similarity |
NPD2015 |
Discontinued |
0.582 |
Remote Similarity |
NPD6771 |
Discontinued |
0.5818 |
Remote Similarity |
NPD2321 |
Approved |
0.5817 |
Remote Similarity |
NPD5259 |
Phase 3 |
0.5813 |
Remote Similarity |
NPD981 |
Phase 2 |
0.5806 |
Remote Similarity |
NPD5524 |
Approved |
0.5806 |
Remote Similarity |
NPD6627 |
Discontinued |
0.5806 |
Remote Similarity |
NPD1597 |
Phase 1 |
0.5806 |
Remote Similarity |
NPD5523 |
Approved |
0.5802 |
Remote Similarity |
NPD4960 |
Approved |
0.5802 |
Remote Similarity |
NPD4959 |
Approved |
0.5801 |
Remote Similarity |
NPD3401 |
Clinical (unspecified phase) |
0.5797 |
Remote Similarity |
NPD6137 |
Clinical (unspecified phase) |
0.5795 |
Remote Similarity |
NPD2716 |
Discontinued |
0.5795 |
Remote Similarity |
NPD2771 |
Approved |
0.5792 |
Remote Similarity |
NPD6173 |
Approved |
0.5785 |
Remote Similarity |
NPD8284 |
Discontinued |
0.5784 |
Remote Similarity |
NPD3460 |
Discontinued |
0.578 |
Remote Similarity |
NPD2048 |
Approved |
0.578 |
Remote Similarity |
NPD2051 |
Approved |
0.578 |
Remote Similarity |
NPD2047 |
Approved |
0.578 |
Remote Similarity |
NPD2043 |
Approved |
0.578 |
Remote Similarity |
NPD21 |
Approved |
0.578 |
Remote Similarity |
NPD2050 |
Clinical (unspecified phase) |
0.578 |
Remote Similarity |
NPD2046 |
Approved |
0.578 |
Remote Similarity |
NPD2049 |
Clinical (unspecified phase) |
0.578 |
Remote Similarity |
NPD2044 |
Approved |
0.578 |
Remote Similarity |
NPD2045 |
Approved |
0.5777 |
Remote Similarity |
NPD6224 |
Clinical (unspecified phase) |
0.5777 |
Remote Similarity |
NPD7021 |
Clinical (unspecified phase) |
0.5775 |
Remote Similarity |
NPD2000 |
Phase 3 |
0.5775 |
Remote Similarity |
NPD3856 |
Clinical (unspecified phase) |
0.5775 |
Remote Similarity |
NPD1999 |
Phase 3 |
0.5775 |
Remote Similarity |
NPD1473 |
Approved |
0.5769 |
Remote Similarity |
NPD1364 |
Approved |
0.5769 |
Remote Similarity |
NPD1365 |
Approved |
0.5769 |
Remote Similarity |
NPD1366 |
Approved |
0.5767 |
Remote Similarity |
NPD3767 |
Approved |
0.5767 |
Remote Similarity |
NPD3766 |
Approved |
0.5767 |
Remote Similarity |
NPD3768 |
Phase 2 |
0.5764 |
Remote Similarity |
NPD3517 |
Clinical (unspecified phase) |
0.5762 |
Remote Similarity |
NPD4044 |
Discontinued |
0.5761 |
Remote Similarity |
NPD5638 |
Approved |
0.5761 |
Remote Similarity |
NPD5229 |
Approved |
0.5761 |
Remote Similarity |
NPD5230 |
Approved |
0.5756 |
Remote Similarity |
NPD2118 |
Approved |
0.5756 |
Remote Similarity |
NPD2119 |
Approved |
0.575 |
Remote Similarity |
NPD5555 |
Phase 1 |
0.5744 |
Remote Similarity |
NPD3859 |
Clinical (unspecified phase) |
0.5743 |
Remote Similarity |
NPD8110 |
Clinical (unspecified phase) |
0.5743 |
Remote Similarity |
NPD2775 |
Phase 1 |
0.5739 |
Remote Similarity |
NPD7241 |
Phase 3 |
0.5739 |
Remote Similarity |
NPD2893 |
Phase 3 |
0.5739 |
Remote Similarity |
NPD7242 |
Phase 3 |
0.5738 |
Remote Similarity |
NPD962 |
Phase 3 |
0.5735 |
Remote Similarity |
NPD6288 |
Clinical (unspecified phase) |
0.573 |
Remote Similarity |
NPD3480 |
Approved |
0.5728 |
Remote Similarity |
NPD7027 |
Phase 3 |
0.5728 |
Remote Similarity |
NPD3127 |
Clinical (unspecified phase) |
0.5727 |
Remote Similarity |
NPD4850 |
Phase 1 |
0.5722 |
Remote Similarity |
NPD6193 |
Clinical (unspecified phase) |
0.5722 |
Remote Similarity |
NPD3609 |
Approved |
0.5722 |
Remote Similarity |
NPD3610 |
Approved |
0.5722 |
Remote Similarity |
NPD6639 |
Clinical (unspecified phase) |
0.5721 |
Remote Similarity |
NPD5820 |
Clinical (unspecified phase) |
0.5714 |
Remote Similarity |
NPD7826 |
Clinical (unspecified phase) |
0.5714 |
Remote Similarity |
NPD704 |
Clinical (unspecified phase) |
0.5714 |
Remote Similarity |
NPD7816 |
Clinical (unspecified phase) |
0.5714 |
Remote Similarity |
NPD4509 |
Discontinued |
0.5714
|
Remote Similarity |
NPD4075 |
Phase 2 |